Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -20252024202320222021202020192018201720162015 7 December 2016 Biocartis launches second liquid biopsy assay Assay co-developed with Merck for detection of KRAS mutations, operating directly on 1 ml blood plasma Non-regulated information 28 November 2016 Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Regulated information 21 November 2016 Disclosure of Outstanding Voting Securities Regulated information 17 November 2016 Thermo Fisher Scientific to Distribute Biocartis’ Idylla™ Automated Molecular Diagnostics Testing Platform in U.S. Inside information Regulated information 17 November 2016 Biocartis Q3 2016 Business Update Regulated information 31 October 2016 Biocartis receives EUR 1.4m grant to support development of its rapid NGS Prep Panels Non-regulated information 18 October 2016 Biocartis receives EUR 2.5m strategic grant from Flemish government to support manufacturing capacity expansion Minister Muyters, Flemish Minister of Work, Economy, Innovation and Sports visits Biocartis on 18 October 2016 to announce the grant Non-regulated information 11 October 2016 AstraZeneca Comparative Study confirms Best-In-Class Status of Idylla™ KRAS Mutation Detection Technology Non-regulated information 7 October 2016 Three Idylla™ Test Performance Studies to be presented at Esmo Oncology Conference Non-regulated information 6 September 2016 Biocartis Announces H1 2016 Results Regulated information Pagination First page « First Previous page ‹‹ … Page 23 Page 24 Page 25 Page 26 Page 27 Current page 28 Page 29 Page 30 Page 31 Next page ›› Last page Last »